Research Center: Syrentis Clinical Research
Location: 401 N Tustin Ave. Suite 130 Santa Ana, CA
Lead Doctor:  Dr John Gregory Duffy
IRB Committee: This study has been reviewed and approved by the Chesapeake Institutional Review Board

Background

Mild Cognitive Impairment (MCI) causes a slight but noticeable decline in mental abilities, such as memory loss and impaired thinking. People with MCI have a much higher risk of going on to develop Alzheimer’s Disease, for which there is currently no cure.

The study is  testing an investigational drug for the treatment of early stage Alzheimer’s disease.

Men and women aged 50 – 85 years old who have noticed a slight decline in their memory and/or other mental abilities are invited to participate.  Participants are required to attend 15 study visits over 2 years and will receive a minimum of $300 for the first 5 visits along with additional compensation upon completion of the study of up to $1,375.

Benefits of Participation

• You may experience an improvement in your memory
• You will be helping to advance medical research for future generations.
• You will receive a minimum of $62 per visit with a total reimbursement of up to $1,375 for completing the study.
• Your study partner is eligible for compensation of up to $1,350 upon completion of the study

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 50 – 85 years old
• Have noticed a slight decline in their memory and/or other mental abilities
• Have a friend/family member who is willing to be your study partner
• Able to attend 15 study visits at the research site over 2 years